Gastrointestinal complications: the most frequent internal complications of systemic sclerosis
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Manifestations of SSc in the gastrointestinal (GI) tract are common, occurring in 50-90% of patients. They typically result from the fibrosis that characterizes this disease. Manifestations of SSc can affect many sites within the GI tract, and patients may experience substantial dysfunction in the processes of motility, digestion, absorption and excretion. Oesophageal dysfunction is the most common GI manifestation, but patients may also experience dysfunction of the stomach, small intestine, colon and rectum, each of which can be responsible for severe and distressing symptoms. At present, few specific therapeutic options are available for the treatment of these patients, but relief of symptoms is often possible with appropriate knowledge and support. It is therefore particularly important to identify, monitor and manage these patients carefully, with a view to minimizing further degeneration and maximizing quality of life.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the gastro-intestinal tract, myofibroblast-induced fibrosis negatively affect motility, digestion, absorption, and excretion (153).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [153]
Citations
Cites
The American Journal of Gastroenterology
(2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.80003397.x · Cited by 2,196
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
Wang, K. K., & Sampliner, R. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01835.x · Cited by 2,014
THE QUARTERLY JOURNAL OF MEDICINE.
(1907) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1907.02530160050010 · Cited by 1,536
Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus
Sampliner, R. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00243-3 · Cited by 817
Validation of rheumatoid arthritis improvement criteria that include simplified joint counts
van Gestel, A. M., Haagsma, C. J., & van Riel, P. L. C. M. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199810)41:10<1845::aid-art17>3.0.co;2-k · Cited by 803
Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus
Sampliner, R. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04267-3 · Cited by 657
Spechler, S. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp012118 · Cited by 587
Gastric Antral Vascular Ectasia: The Watermelon Stomach
Jabbari, M., Cherry, R., Lough, J. O., Daly, D. S., Kinnear, D. G., & Goresky, C. A. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80080-3 · Cited by 443
Gastrointestinal motility disorders in scleroderma
Sjogren, R. W. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370902 · Cited by 381
SCUSSEL-LONZETTI, L., JOYAL, F., RAYNAULD, J.-P., ROUSSIN, A., RICH, É., GOULET, J.-R., RAYMOND, Y., & SENÉCAL, J.-L. (2002) · Medicine · doi:10.1097/00005792-200203000-00005 · Cited by 361
Research works printed but not linked: 12
- Clements, 2003, Clinical and experimental rheumatology, 21, S15
- MEDSGER, 1971, Annals of Internal Medicine, 75, 369, 10.1059/0003-4819-75-3-369 · doi:10.1059/0003-4819-75-3-369
- Jacobsen, 2001, The Journal of Rheumatology, 28, 2454
- Poirier, 1972, The American journal of gastroenterology, 58, 30
- 2006, SCLERODERMA CARE RES, 3, 14
- 2000, Oncology, 14, 507
- Wong, 2001, Cancer Research, 61, 8284
- 1985, 89, 485
- Derk, 2006, The Journal of Rheumatology, 33, 1113
- 1984, 87, 1165
- Calamia, 2000, Clinical and experimental rheumatology, 18, 605
- 1994, The Quarterly journal of medicine, 87, 495
Cited by
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
“In the gastro-intestinal tract, myofibroblast-induced fibrosis negatively affect motility, digestion, absorption, and excretion (153).”
BackgroundGyger, G., & Baron, M. G. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0217-3 · Cited by 119
“For situations that do not respond to the above therapies, parenteral nutrition [52] or enteral nutrition via jejunostomy may be considered [6].”
BackgroundGastrointestinal involvement in systemic sclerosis
Savarino, E. V., Furnari, M., de Bortoli, N., Martinucci, I., Bodini, G., Ghio, M., & Savarino, V. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.03.029 · Cited by 109
“, gastroparesis), a percutaneous gastrostomy may represent the sole alternative, both for feeding and drainage [102].”
BackgroundGyger, G., & Baron, M. G. (2015) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.04.007 · Cited by 108
Management of Gastrointestinal Involvement in Scleroderma
Nagaraja, V., McMahan, Z. H., Getzug, T. E., & Khanna, D. (2015) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-014-0005-0 · Cited by 100
Metadata
- Authors
- Forbes, A., & Marie, I.
- Affiliations
- University College Hospital (GB)
- Corresponding author
- Forbes, A.
- ORCID
- Forbes, A.
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-05-31
- Volume
- 48
- Issue
- Supplement 3
- Pages
- iii36-iii39
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W2153393058
- Cited by
- 162
- References
- 51
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 9 · 2020: 7 · 2019: 17 · 2018: 13 · 2017: 9 · 2016: 16 · 2015: 14 · 2014: 4 · 2013: 11 · 2012: 14
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lara D. Veeken (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- University College London
- Actelion Pharmaceuticals
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Keywords
- systemic sclerosis, gastrointestinal complications, esophageal dysfunction, gastric dysfunction, colonic dysfunction, rectal dysfunction, gastrointestinal motility, symptom management, quality of life
- MeSH terms
- Endoscopy, Esophageal Diseases, Gastrointestinal Diseases, Humans, Scleroderma, Systemic, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gastrointestinal complications: the most frequent internal complications of systemic sclerosis. https://app.cochat.ai/papers/10.1093/rheumatology/ken485
- The paper
- Forbes, A., & Marie, I. (2009). Gastrointestinal complications: the most frequent internal complications of systemic sclerosis. Rheumatology. https://doi.org/10.1093/rheumatology/ken485
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.